Get started
Novartis AG Sponsored ADRNovartis AG Sponsored ADRNovartis AG Sponsored ADR

Novartis AG Sponsored ADR

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast Seasonals Bonds

NOTA chart


Full chart

NOTA upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪205.80 B‬ EUR
Dividend yield (indicated)
2.67%
Price to earnings Ratio (TTM)
18.0
Basic EPS (TTM)
6.0 EUR
Net income (FY)
‪11.53 B‬ EUR
Revenue (FY)
‪48.58 B‬ EUR
Shares float
‪1.90 B‬
Beta (1Y)
0.33

About Novartis AG


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Vasant Narasimhan
Website
novartis.com
Headquarters
Basel
Founded
1996
ISIN
US66987V1098
FIGI
BBG000NDLRG5
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Check out other big names from the same industry as NOTA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

NOTA news



Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

NOTA highest yielding bonds


N
NVS5894398
Novartis Capital Corp. 3.8% 18-SEP-2029
Yield to maturity
—
Maturity date
Sep 18, 2029
N
NVS5894400
Novartis Capital Corp. 4.2% 18-SEP-2034
Yield to maturity
—
Maturity date
Sep 18, 2034
A3LZ2R
Novartis AG 1.65% 18-JUN-2031 2024-18.06.31 REG S
Yield to maturity
—
Maturity date
Jun 18, 2031
N
NVS5894399
Novartis Capital Corp. 4.0% 18-SEP-2031
Yield to maturity
—
Maturity date
Sep 18, 2031
N
NVS4950565
Novartis Capital Corp. 2.0% 14-FEB-2027
Yield to maturity
—
Maturity date
Feb 14, 2027
N
NVS5894401
Novartis Capital Corp. 4.7% 18-SEP-2054
Yield to maturity
—
Maturity date
Sep 18, 2054
N
NVS3904288
Novartis Capital Corp. 3.7% 21-SEP-2042
Yield to maturity
—
Maturity date
Sep 21, 2042
N
XS176904160
Novartis Finance S.A. 1.7% 14-AUG-2038
Yield to maturity
—
Maturity date
Aug 14, 2038
N
XS149282548
Novartis Finance S.A. 0.625% 20-SEP-2028
Yield to maturity
—
Maturity date
Sep 20, 2028
CH27019100
Novartis AG 1.05% 11-MAY-2035
Yield to maturity
—
Maturity date
May 11, 2035
N
US66989HAR9
Novartis Capital Corp. 2.2% 14-AUG-2030
Yield to maturity
—
Maturity date
Aug 14, 2030

See all NOTA bonds 

Sparks


Curated watchlists where NOTA is featured.

See all sparks